Neurology · 510(k) · 2023
Alpha Control Liner System (ACLS)
Coapt. Cleared by FDA on 11 January 2023 under submission K223738, product code GXY (electrode, cutaneous). What FDA's record says, in FDA's words.
Device record · K223738
- Device. Alpha Control Liner System (ACLS)DEVICE
- Company. CoaptCOMPANY
- Decision. 11 January 2023, 510(k), substantially equivalent (special review); received 14 December 2022DECISION
- Panel. NeurologyPANEL
- Product code. GXY, Electrode, CutaneousCODE
- Regulation. 21 CFR 882.1320, Class IIREG
- Source. FDA database entry · decision document (10 pages)SOURCE
Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.
What FDA cleared it for
The Indications for Use statement, verbatim, from the decision document.
, principles of operation, technological characteristics, materials used, and performance. The comparison of the devices provides more detailed information regarding the basis for the determination of substantial equivalence. The subject device does not raise any new issues of safety or efficacy based on the similarities to the predicate device. Coapt, LLC Special 510(k) Premarket Submission Alpha Control Liner Manufacturer: Coapt, LLC WillowWood Global LLC Device
What the statement says
Pattern matches on the Indications for Use text. Each line is a fact that the text contains the words, not a finding about the device.
- Mentionsnone of the tracked terms matched
Adverse-event reports in MAUDE, by product code
As of , MAUDE held 534 reports filed against devices carrying product code GXY. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification. The latest reports, in the reporter’s words:
4 September 2026 · Malfunction · BIS · COVIDIEN · report 2936999-2026-00374
3 September 2026 · Injury · Biomet SpinalPak / OrthoPak · EBI, LLC. · report 0002242816-2026-00098
It was reported that the patient experienced skin irritation with the 63B electrodes. The patient discussed the issue with their doctor and advised that their doctor is in the process of prescribing a different device. No further information was provided.
2 September 2026 · Malfunction · BIS · COVIDIEN · report 2936999-2026-00368
2 September 2026 · Malfunction · BIS · COVIDIEN · report 2936999-2026-00370
25 August 2026 · Injury · Biomet SpinalPak / OrthoPak · EBI, LLC. · report 0002242816-2026-00096
It was reported that the electrodes irritated the patient¿s skin. The patient stated that their doctor would like them to use a different unit. No further information was provided.
Where this fits
This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.
More devices under product code GXY, in Neurology, or cleared in 2023. The whole record is at FDA AI-enabled medical devices.
A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.